Etamsylate

DRUG4 trials

Sponsors

Astrazeneca AB, Astrazeneca AB, University of Sfax, First Affiliated Hospital of Zhejiang University, October 6th university and Ain shams Maternity hospital

Conditions

Hematopoietic Stem Cell TransplantationPostpancreatectomy HemorrhageReversal of anticoagulation effect in patients on a FXa inhibitor (apixabanThrombocytopeniaand who have a major risk of bleeding.or edoxaban) who require urgent surgery or procedurepost partum hemorrhagerivaroxaban

Phase 1

Tranexamic acid versus etamsylate in reducing blood loss in patients with high risk of postpartum hemorrhage

Active, not recruitingPACTR202205750416982

October 6th university and Ain shams Maternity hospitalpost partum hemorrhage

Start: 2022-04-01Target: 180Updated: 2026-01-27

Phase 3

A Randomized Study of Andexanet Alfa Compared to Usual Care in Patients Receiving a Factor Xa Inhibitor who Require Urgent Surgery or Procedure (ANNEXA-RS)

CompletedCTIS2022-501353-37-00

Astrazeneca AB, Astrazeneca ABand who have a major risk of bleeding., or edoxaban) who require urgent surgery or procedure, Reversal of anticoagulation effect in patients on a FXa inhibitor (apixaban +1

End: 2024-06-13Target: 467Updated: 2024-02-19

Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT

RecruitingNCT07442513

First Affiliated Hospital of Zhejiang UniversityHematopoietic Stem Cell Transplantation, Thrombocytopenia

Start: 2025-12-16End: 2027-10-31Target: 404Updated: 2026-03-02

Unknown Phase

Can Administration of Etamsylate Reduce Postpancreatectomy Hemorrhage

Not yet recruitingNCT06190535

University of SfaxPostpancreatectomy Hemorrhage

Start: 2024-01-01End: 2025-03-30Target: 20Updated: 2024-01-05

Related Papers

Tranexamic Acid Versus Etamsylate in Reducing Blood Loss During Normal Vaginal Delivery in Patients with High Risk of Postpartum Hemorrhage: Randomized Controlled Trial

The Egyptian Journal of Hospital Medicine2023-07-011 citations